ECSP982371A - DERIVATIVES OF SULFONIL UREA - Google Patents

DERIVATIVES OF SULFONIL UREA

Info

Publication number
ECSP982371A
ECSP982371A ECSP982371A ECSP982371A EC SP982371 A ECSP982371 A EC SP982371A EC SP982371 A ECSP982371 A EC SP982371A EC SP982371 A ECSP982371 A EC SP982371A
Authority
EC
Ecuador
Prior art keywords
acute
disease
injury
sulfonil
urea
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Mark Anthony Dornbroski
James Frederick Eggler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982371 priority Critical patent/ECSP982371A/en
Publication of ECSP982371A publication Critical patent/ECSP982371A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un compuesto de la fórmula (gráfico), en el que R y R son tal como se han definido anteriormente, útil en el tratamiento y estado seleccionado entre el grupo formado por meningitis y salpingitis, choque séptico, coagulación intravascular diseminada, y/o el sindrome de distrés respiratorio en adultos, inflamación aguda o crónica, artritis, colangitis, colitis, encefalitis, endocarditis, glomerulonefritis, hepatitis, miocarditis, pancreatitis, pericarditis, lesiones por reperfusión, vasculinitis, hipersensibilidad aguda y retardada, rechazo de injertos, y enfermedad del huésped frente al injerto, enfermedades auto-inmunes que incluyen la diabetes ellitus del tipo 1 y la esclerosis múltiple enfermedades periodonatas, fibrosis pulmonar intersticial, cirrosis, esclerosis sistémica, formación queloide, tumores que producen la IL-1 como un factor de crecimiento autocrino, caquexia, enfermedad de Alzheimer, lesión por percusión, represión, ateroesclerosis y osteoporosis en un mamífero, incluyendo un humano.A compound of the formula (graph), in which R and R are as defined above, useful in the treatment and condition selected from the group consisting of meningitis and salpingitis, septic shock, disseminated intravascular coagulation, and / or the respiratory distress syndrome in adults, acute or chronic inflammation, arthritis, cholangitis, colitis, encephalitis, endocarditis, glomerulonephritis, hepatitis, myocarditis, pancreatitis, pericarditis, reperfusion injury, vasculinitis, acute and delayed hypersensitivity, graft rejection, and disease of the host versus graft, autoimmune diseases including type 1 diabetes ellitus and multiple sclerosis, periodontal diseases, interstitial lung fibrosis, cirrhosis, systemic sclerosis, keloid formation, tumors that produce IL-1 as an autocrine growth factor, cachexia, Alzheimer's disease, percussion injury, repression, atherosclerosis and osteoporosis in m amifer, including a human.

ECSP982371 1998-01-20 1998-01-20 DERIVATIVES OF SULFONIL UREA ECSP982371A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982371 ECSP982371A (en) 1998-01-20 1998-01-20 DERIVATIVES OF SULFONIL UREA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982371 ECSP982371A (en) 1998-01-20 1998-01-20 DERIVATIVES OF SULFONIL UREA

Publications (1)

Publication Number Publication Date
ECSP982371A true ECSP982371A (en) 1998-12-29

Family

ID=42043294

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982371 ECSP982371A (en) 1998-01-20 1998-01-20 DERIVATIVES OF SULFONIL UREA

Country Status (1)

Country Link
EC (1) ECSP982371A (en)

Similar Documents

Publication Publication Date Title
CO4920230A1 (en) DERIVATIVES OF SULFONIL UREA
RU99105213A (en) APPLICATION OF THE CREATING AGENT OF CLIOCHINOL FOR THE PRODUCTION OF THE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EE05105B1 (en) Phenphenanthridines, their use in the manufacture of medicaments, and medicaments containing them
ATE460481T1 (en) METHOD FOR INHIBITING THE EXPRESSION OF A TARGET GENE AND MEDICATION FOR THE THERAPY OF A TUMOR DISEASE
IL101836A0 (en) Pharmaceutical compositions containing 1,3-oxathiolane nucleoside derivatives
NZ507350A (en) Semi-synthetic ecteinascidins and use in treatment of tumors
JPH09114449A (en) Antibacterial keyboard
DE69326849D1 (en) Use of human atrio-natriuretic peptide for the manufacture of a medicament for the treatment of respiratory distress syndrome in adults
ZA200201408B (en) Use of docetaxel for treating hepatocellular carcinoma.
ES2191850T3 (en) DEVICE FOR CLEANING THE ORAL CAVITY.
PL319677A1 (en) Method of obtaining p-chiral analoques of nucleotides
Coldstream The Cesnola painter: a change of address
CY1107756T1 (en) Sulfate Analogs of 21-Hydroxy-6, 19-Oxidoprogesterone (21OH-6OP)
DE3870908D1 (en) PARTICLES FROM STABILIZED PERSONAL OXYGEN COMPOUNDS, THEIR PRODUCTION AND THE COMPOSITIONS CONTAINING THEM.
MXPA05009972A (en) Water-soluble phenylpyridazine derivative and medicine containing the same.
USD156105S (en) Design for a glove
USD203039S (en) Stroller
USD156103S (en) Design for a glove
JPS5524150A (en) Anti-malignant-tumor agent
USD232704S (en) Resuscitator valve trigger
CN208301207U (en) One kind, which can divulge information, justifies rolling hair comb
JPS5519244A (en) Anti-malignant tumor agent
USD232391S (en) Accessory hairpiece
USD189411S (en) Spray nozzle
USD156098S (en) Design fob a glove